Deeper Dive: Understanding Lyra Therapeutics Inc (LYRA) Through its Various Ratios

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Lyra Therapeutics Inc (NASDAQ: LYRA) closed at $0.20 in the last session, up 4.37% from day before closing price of $0.19. In other words, the price has increased by $4.37 from its previous closing price. On the day, 1.27 million shares were traded. LYRA stock price reached its highest trading level at $0.2048 during the session, while it also had its lowest trading level at $0.1904.

Ratios:

We take a closer look at LYRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 1.71 whereas as Long-Term Debt/Eq ratio is at 1.52.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.

On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYRA now has a Market Capitalization of 12980262 and an Enterprise Value of -3321748. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.83 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at -2.258 whereas that against EBITDA is 0.05.

Stock Price History:

Over the past 52 weeks, LYRA has reached a high of $6.79, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -17.43%, while the 200-Day Moving Average is calculated to be -88.70%.

Shares Statistics:

According to the various share statistics, LYRA traded on average about 1.46M shares per day over the past 3-months and 4119730 shares per day over the past 10 days. A total of 57.21M shares are outstanding, with a floating share count of 54.79M. Insiders hold about 16.29% of the company’s shares, while institutions hold 46.47% stake in the company. Shares short for LYRA as of 1731628800 were 2378932 with a Short Ratio of 1.39, compared to 1728950400 on 2140610. Therefore, it implies a Short% of Shares Outstanding of 2378932 and a Short% of Float of 4.5300003.

Most Popular